Page last updated: 2024-08-25
7-deoxyadriamycin aglycone and Carcinoma, Anaplastic
7-deoxyadriamycin aglycone has been researched along with Carcinoma, Anaplastic in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Pritsos, CA; Yee, SB | 1 |
Other Studies
1 other study(ies) available for 7-deoxyadriamycin aglycone and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Reductive activation of doxorubicin by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Chromatography, High Pressure Liquid; Doxorubicin; Electrons; Female; Hydrogen-Ion Concentration; Kinetics; Mammary Neoplasms, Experimental; Mice; NAD; Naphthacenes; Oxidation-Reduction; Oxygen Consumption; Reactive Oxygen Species; Xanthine Dehydrogenase; Xanthine Oxidase | 1997 |